A trial looking at ovarian protection for premenopausal women having chemotherapy for breast cancer (OPTION)

Overview

Cancer types:

Status:

Results

Phase:

Phase 3

Details

This trial was trying to find out if goserelin (Zoladex) could protect the ovaries, and so prevent early menopause, in women who were having chemotherapy for . Cancer Research UK supported this trial.

Recruitment start: 26 August 2004

Recruitment end: 31 December 2009

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Rob Leonard

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/04/004.

Last reviewed: 29 August 2017

CRUK internal database number: 336

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.